Mar 1, 2019

Zarif's resignation likely a strategic move to deflect Iran deal criticism

Iranian Foreign Minister Mohammad Javad Zarif on Feb. 19, 2019, in Beijing. Photo: How Hwee Young/Pool via Getty Images

Iranian President Hassan Rouhani formally rejected Foreign Minister Mohammad Javad Zarif’s resignation on Wednesday, calling the move “against the country’s interests,” and Zarif has now returned to his duties.

Why it matters: Zarif, who was instrumental to the 2015 Iran nuclear deal, benefitted from an immense outpouring of public and personal support. Had his resignation been accepted, it might have indicated an overt desire on behalf of the government to leave the nuclear deal and entertain escalation.

Although factionalism remains a potent force in Iran, key hardline power players such as the Commander of the Islamic Revolutionary Guard Corps (IRGC) Quds Force offered Zarif verbal approbation, while the editor-in-chief of Kayhan newspaper and reportedly even the Supreme Leader told him to stay put.

What they’re saying: Some outlets have cited Zarif’s recent remarks about his exclusion from meetings during Syrian President Bashar al-Assad’s visit to Iran as the latest reason for his resignation. Zarif has sought to cultivate the image of a sober statesman, a task aided by his popularity in the West.

  • But his habitual outbursts — during the Iran deal negotiations, at the Munich security conference, and most recently, taking to social media to resign — paint a picture of an egoist as much as a strategist.

Yes, but: Real foreign policy decision-making remains concentrated in the hands of the Supreme Leader and military elite of the IRGC. For Zarif to resign over differences with this lot, as some observers have speculated, would first require him to have genuine disagreements that in all likelihood don’t exist.

  • It would also mean that Zarif failed to understand the role the foreign minister plays in the Islamic Republic, which is to convey Iran’s mere stylistic change in the past six years as substantive progress.

The bottom line: Most likely, Zarif was simply feigning to fall on his sword to deflect pressure from Rouhani, who has faced criticisms for the lack of dividends from the nuclear deal. The predictable public outcry in favor of Zarif buys space for their strategy: outlast Washington’s pressure policy by staying within the broad boundaries of the nuclear deal, while stigmatizing the Trump administration to drive a wedge between the transatlantic alliance.

Behnam Ben Taleblu is a senior fellow at the Foundation for Defense of Democracies.

Go deeper

Trump weighs quarantine of New York, New Jersey and Connecticut

Data: The Center for Systems Science and Engineering at Johns Hopkins; Map: Andrew Witherspoon/Axios

President Trump said on Saturday he is considering a "short term" quarantine of New York, New Jersey and parts of Connecticut — states that have already taken steps to quarantine residents and promote social distancing.

The big picture: With 112,000 people infected, the U.S. has the most COVID-19 cases in the world, exceeding China and Italy, per data from Johns Hopkins. A second wave of American cities, including Boston, Detroit, New Orleans and Philadelphia, are reporting influxes of cases.

Go deeperArrowUpdated 12 mins ago - Health

Q&A: Minimizing your coronavirus risk

Illustration: Aïda Amer/Axios

As the coronavirus continues to spread throughout the U.S., Axios is answering readers' questions about the pandemic — how it spreads, who's at risk, and what you can do to stay safe.

What's new: This week, we answer five questions on smokers' vulnerability, food safety, visiting older parents, hair cut needs, and rural vs. urban impact.

The other coronavirus test we need

Illustration: Sarah Grillo/Axios

Researchers are racing to develop tests that detect whether someone may have developed immunity to the coronavirus, which could help society return to normal faster.

Why it matters: These tests could help people know if they are able to go back to work, as well as aid researchers in tracking the scale and death rate of the disease — key data for current and future pandemic policies.

Go deeperArrow40 mins ago - Health